This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medical Gases And Equipment Market Is Expected To Reach USD 9 Billion Globally In 2018: Transparency Market Research

NEW YORK, March 20, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research ( http://www.transparencymarketresearch.com) " Medical Gases and Equipment Market (Pure Gases, Gas Mixtures, Oxygen, Nitrous Oxide, Carbon Dioxide-Oxygen, Nitrous Oxide-Oxygen, Manifolds, Vacuum Systems) -  Global Industry Analysis, Size, Share, Growth and Forecast, 2012  -  2018, " in 2011, the global medical gases and equipment market was calculated at USD 5.3 billion and is expected to grow at a CAGR of 8% from 2012 to 2018, to reach an estimated value of USD 9 billion in 2018.

Browse the full report at  http://www.transparencymarketresearch.com/medical-gases-and-equipment.html

The implementation of the U.S. Food and Drug Administration Safety and Innovation Act in July 2012, which includes the elimination of drug user fees for manufacturers and grants them the right to file for intellectual property rights for new products, is the most important driver for the market. Furthermore, aging global population and the rapidly growing ancillary home healthcare market are some of the other drivers for the global medical gases and equipment market.

Medical equipment segment held majority of the market share in 2011 and are expected to maintain their market position in terms of market share till 2018. In the global medical pure gas market, the medical grade oxygen market held the highest share in 2011 and is expected to increase its market share by 2018, owing to the presence of a large patient pool suffering from respiratory diseases and the rising number of patients admitted for emergency medical care. Nitrous oxide followed oxygen in terms of market share in 2011; however, its market share is expected to plummet by 2018 due to the availability of anesthetic drugs with high profit margins and the growing use of medical air as an alternative anesthetic gas.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs